Mednet Logo
HomeRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

How long after biopsy is it safe to place rectal spacer when treating a patient definitively for prostate cancer?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · David Geffen School of Medicine at UCLA

Depends on the method of biopsy. Transperineal, think it would be safe to do this immediately. Transrectal biopsy I would be more concerned about infection and would wait 3 days.

Would you recommend nodal irradiation in a patient with breast cancer with a single positive sentinel node and a low Oncotype who does not receive chemotherapy?

3
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Michigan Healthcare Professionals, PC

Without knowing all the details, this sounds like a patient that may have been eligible for Z11 (early stage patients treated with BCS and SLN bx who were found to have 1-2 positive SLN then randomized to ALND vs no further surgery with all patients receiving at least tangents to breast). There was ...

How do you approach rectal cancer with a solitary bone metastasis that is biopsy proven?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Brigham and Women's Hospital

This is a much less common scenario than oligometastatic disease to the liver or lung, but as control rates for bone metastases treated with SBRT are showing promise, the approach may be similar to that taken for patients with more common sites of oligometastatic rectal cancer. We would typically st...

How, if at all, do you use biozorb to help guide your external beam partial breast irradiation volumes?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Allegheny Health Network, Pittsburgh

I currently do not use Biozorb when I deliver EBRT APBI. I have had good success with 5 and 15 fraction PBI regimens using the seroma and clips. Also, the studies that evaluated EBRT APBI did not use the device. There are situations where it can be helpful for example with an UOQ tumor and a single ...

At what point would you no longer offer adjuvant radiation for adenoid cystic ca of the head and neck?

1
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Texas MD Anderson Cancer Center

While the traditional start within 6 weeks is embedded in our postoperative management algorithms, and seems very intuitive, even this has little evidence to support it; though for SCC there is some literature to support the overall "package". Additionally, this is used to argue for the best outcome...

Would you consider adjuvant radiation for R1 resection for thymoma with solitary pleural deposit along diaphragm?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · VA New Jersey Healthcare System - East Orange campus.

In my experience, anytime the pleural space is violated nothing good comes from it because if you "treat" one spot, others will pop-up which will ultimately result in the demise of the patient(s). There is a 1997 paper for carcinomas involving the p-space which indicated that these patients do much ...

In patients with inflammatory bowel disease with low rectal cancer with planned proctocolectomy, would you consider creation of a pouch?

1 Answers

Mednet Member
Mednet Member
Surgical Oncology · Temple University

This is a very difficult case- are you speaking of Ulcerative Colitis or Crohn's disease? If UC - can consider pouch but really depends on the stage of the primary rectal cancer. If neoadjuvant chemoradiation is given, the likelihood of an ileoanal J-pouch functioning appropriately is low. Generally...

Is it appropriate to treat unresectable secretory insulinoma of tail of the pancreas with radiation therapy?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Memorial Sloan-Kettering Cancer Center

Absolutely, it is the preferred treatment. Well differentiated functional NETs of the pancreas have been considered a resistant histology. However, the available data are based on palliative doses (BED<50Gy). It is an open question, but very likely that ablative doses (BED>100Gy) can overcome this r...

In the case of a high upper outer quadrant early stage breast cancer without adverse histological factors, would you omit boosting the breast lumpectomy cavity if the treatment area would involve a significant portion of axilla due to risk of lymphedema?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Michigan Healthcare Professionals, PC

There is a great thread on when to boost from TheMedNet- so that's a good place to start - to figure out if they need a boost or not. It shouldn't be just histologic factors - age is also important. To paraphrase, what they said - if you'd consider skipping RT altogether, then those patients don't n...

In contemplating neoadjuvant RT, how would you manage a large, non-RT-induced angiosarcoma of the right breast in a young female?

1
2 Answers

Mednet Member
Mednet Member
Medical Oncology · Emory University

I would have her get a mastectomy first. 1. You want your surgeons in their comfort zones. Preop treatment of any sort is a discussion to have with her surgeon in advance of doing anything. Breast surgeons who see 99.9% adenocarcinoma are used to preop chemo but not usually preop radiation. 2. Radi...